According to the US FDA, a biosimilar agent is one thar: A . Has the same route
Fantastic news! We've Found the answer you've been seeking!
Question:
According to the US FDA, a biosimilar agent is one thar: A Has the same route of administration as a reference product.. B Is available in different dosage from the reference product. C Uses a different mechanism of action from a reference product. D Is seldom interchangeable with a reference product
Related Book For
Understanding Business Statistics
ISBN: 978-1118145258
1st edition
Authors: Stacey Jones, Tim Bergquist, Ned Freed
Posted Date: